Optimisation of mechanical ventilation in patients with ARDS caused by COVID-19 based on individual PEEP determination by PEEP titration using electrical impedance tomography - a controlled clinical pilot trial
- Conditions
- J80U07.1Adult respiratory distress syndromeCOVID-19, virus identified
- Registration Number
- DRKS00030886
- Lead Sponsor
- niversitätsklinikum Augsburg
- Brief Summary
Because of the cancellation of the study, no sufficient results could be achieved.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting stopped after recruiting started
- Sex
- All
- Target Recruitment
- 10
1. ARDS as defined by Berlin meet the following criteria (all):
a.Sudden onset
b.Bilateral infiltrates in chest x-ray or CT chest
c.PaO2/FiO2 < 300
d.No clinical evidence of cardiac cause of respiratory failure
2. need for intubation and invasive ventilation
3. written informed consent
1. age < 18 years
2. known pulmonary fibrosis/restrictive ventilation disorder
3. severe emphysema
4. pregnancy and breastfeeding
5. severe cardiac disease (New York Heart Association classification III or IV, acute ischaemic event, persistent ventricular arrhythmia)
6. pre-existing neuromuscular disease
7. implanted pacemaker or ICD
8. participation in other interventional studies within the last three months
9. severity of illness that makes death within the next 24 h highly probable in the investigator's opinion
10. DNR/DNI order
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method PaO2/FiO2 one hour after setting PEEP in each group
- Secondary Outcome Measures
Name Time Method Adjusted PEEP<br>Barotrauma<br>Haemodynamic instability <br>Description of ventilation distribution in early ARDS<br>Effects of PEEP determination on ventilation distribution<br>Correlation of physiological parameters of lung function with the results of quantitative CT analysis<br>Histological degree of lung damage (if autopsy is performed)